We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance & Risk Management 2006

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

‘Pharmacovigilance & Risk Management 2006’, (28/29 November 2006, Berlin, Germany), will provide two days of brand new, practical case-study based presentations and debate on the critical issues facing post-marketing pharmacovigilance today.

Along with an audience of professionals from pharmacovigilance departments across Europe, attendees will have the opportunity to learn from and debate with a panel of key experts from major pharmaceutical manufacturers and biotechs, including: Organon, Merck KgaA, Novartis Vaccines, Amgen, Eli Lilly, GlaxoSmithKline, SERVIER Group, BfARM.

These experts will be discussing their latest thinking, practical strategies and personal insights on a wide range of difficult and uncertain aspects of pharmacovigilance best practice, as well as their preparations for the future evolution of this critical function. Key themes under discussion include:

• Anticipating and preparing for changing EU legislation
• Practical risk minimisation tools and techniques
•  Maintaining a viable PV service whilst managing increased workloads and constant change
• Assessing the impact of the revised Volume 9
• Anticipating and preparing for pharmacovigilance inspections

Benefit from making new business contacts, from spending two intense days of debate and discussion on these key areas of ongoing industry concern - reserve your seat at this event straight away.

Reserve your place now by simply calling our Customer Services Team on +44 (0)20 7753 4268, access the website  or email: events@vibevents.com (Please quote reference "ADMET" on all communication).